4.6 Editorial Material

Oestrogenic contribution to sex-biased left ventricular remodelling: The male implication

Journal

INTERNATIONAL JOURNAL OF CARDIOLOGY
Volume 343, Issue -, Pages -

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.ijcard.2021.09.020

Keywords

-

Funding

  1. European Union [101024324]
  2. Icelandic Research Fund [217946-051]
  3. Icelandic Cancer Society Research Fund
  4. University of Iceland Research Fund [1237-1232583]
  5. Marie Curie Actions (MSCA) [101024324] Funding Source: Marie Curie Actions (MSCA)

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Endocrinology & Metabolism

Estrogen-related mechanisms in sex differences of hypertension and target organ damage

Andrea Rodrigues Sabbatini, Georgios Kararigas

BIOLOGY OF SEX DIFFERENCES (2020)

Editorial Material Endocrinology & Metabolism

Editorial: New Insights into Estrogen/Estrogen Receptor Effects in the Cardiac and Skeletal Muscle

Dawn A. Lowe, Georgios Kararigas

FRONTIERS IN ENDOCRINOLOGY (2020)

Article Cardiac & Cardiovascular Systems

KLF5 Is Induced by FOXO1 and Causes Oxidative Stress and Diabetic Cardiomyopathy

Ioannis D. Kyriazis, Matthew Hoffman, Lea Gaignebet, Anna Maria Lucchese, Eftychia Markopoulou, Dimitra Palioura, Chao Wang, Thomas D. Bannister, Melpo Christofidou-Solomidou, Shin-Ichi Oka, Junichi Sadoshima, Walter J. Koch, Ira J. Goldberg, Vincent W. Yang, Agnieszka B. Bialkowska, Georgios Kararigas, Konstantinos Drosatos

Summary: The study revealed that diabetic cardiomyopathy (DbCM) is associated with increased cardiac expression of KLF5, which is regulated by FOXO1. KLF5 induces DbCM by promoting oxidative stress through NOX4 and ceramide accumulation in the heart. Inhibiting KLF5 could alleviate superoxide formation and improve cardiac function in diabetic mice.

CIRCULATION RESEARCH (2021)

Letter Medicine, General & Internal

In Reply - COVID-19, the Female Immune Advantage, and Cardiovascular Impact

Oliver Ritter, Georgios Kararigas

MAYO CLINIC PROCEEDINGS (2021)

Article Cardiac & Cardiovascular Systems

Genome-wide association analysis in dilated cardiomyopathy reveals two new players in systolic heart failure on chromosomes 3p25.1 and 22q11.23

Sophie Garnier, Magdalena Harakalova, Stefan Weiss, Michal Mokry, Vera Regitz-Zagrosek, Christian Hengstenberg, Thomas P. Cappola, Richard Isnard, Eloisa Arbustini, Stuart A. Cook, Jessica van Setten, Jorg J. A. Calis, Hakon Hakonarson, Michael P. Morley, Klaus Stark, Sanjay K. Prasad, Jin Li, Declan P. O'Regan, Maurizia Grasso, Martina Mueller-Nurasyid, Thomas Meitinger, Jean-Philippe Empana, Konstantin Strauch, Melanie Waldenberger, Kenneth B. Marguiles, Christine E. Seidman, Georgios Kararigas, Benjamin Meder, Jan Haas, Pierre Boutouyrie, Patrick Lacolley, Xavier Jouven, Jeanette Erdmann, Stefan Blankenberg, Thomas Wichter, Volker Ruppert, Luigi Tavazzi, Olivier Dubourg, Gerard Roizes, Richard Dorent, Pascal de Groote, Laurent Fauchier, Jean-Noel Trochu, Jean-Francois Aupetit, Zofia T. Bilinska, Marine Germain, Uwe Voelker, Daiane Hemerich, Ibticem Raji, Delphine Bacq-Daian, Carole Proust, Paloma Remior, Manuel Gomez-Bueno, Kristin Lehnert, Renee Maas, Robert Olaso, Ganapathi Varma Saripella, Stephan B. Felix, Steven McGinn, Laetitia Duboscq-Bidot, Alain van Mil, Celine Besse, Vincent Fontaine, Helene Blanche, Flavie Ader, Brendan Keating, Angelique Curjol, Anne Boland, Michel Komajda, Francois Cambien, Jean-Francois Deleuze, Marcus Doerr, Folkert W. Asselbergs, Eric Villard, David-Alexandre Tregoueet, Philippe Charron

Summary: This study conducted the largest genome-wide association study on dilated cardiomyopathy, identifying new DCM-associated loci on chromosomes 3p25.1 and 22q11.23. A genetic risk score based on risk alleles at these loci showed a 3-fold increased risk of DCM. Functional analyses suggest SLC6A6 and SMARCB1 as candidate genes at the identified loci, shedding light on novel biological pathways underlying heart failure.

EUROPEAN HEART JOURNAL (2021)

Review Biochemistry & Molecular Biology

Oestrogenic Regulation of Mitochondrial Dynamics

Siavash Beikoghli Kalkhoran, Georgios Kararigas

Summary: Biological sex influences disease development and progression. The hormone 17 beta-oestradiol (E2), along with its receptors, plays a major role in sex differences. E2 regulates mitochondrial dynamics by modulating fusion-fission dynamics and affects cellular metabolism. This article discusses the regulatory pathways of E2 in cardiovascular and nervous systems and concludes that E2 maintains mitochondrial function by promoting fusion and attenuating fission.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Editorial Material Physiology

SEX-BIASED MECHANISMS OF CARDIOVASCULAR COMPLICATIONS IN COVID-19

Georgios Kararigas

PHYSIOLOGICAL REVIEWS (2022)

Review Cardiac & Cardiovascular Systems

Role of Biological Sex in the Cardiovascular-Gut Microbiome Axis

Shuangyue Li, Georgios Kararigas

Summary: There has been a recent surge of interest in the role of gut microbiota in cardiovascular diseases, with a focus on the potential sex differences in microbial composition and function. This article discusses the contribution of gut microbiota in the development and progression of CVD, as well as how sex hormones may influence the gut microbiome. Understanding these relationships could lead to innovative strategies for preventing, diagnosing, and treating CVD in both men and women.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)

Editorial Material Cardiac & Cardiovascular Systems

Estrogen and Cardiovascular Health

Hester M. den Ruijter, Georgios Kararigas

FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)

Review Cardiac & Cardiovascular Systems

Cardiovascular complications of diabetes: role of non-coding RNAs in the crosstalk between immune and cardiovascular systems

Gaia Spinetti, Martina Mutoli, Simona Greco, Federica Riccio, Soumaya Ben-Aicha, Franziska Kenneweg, Amela Jusic, David de Gonzalo-Calvo, Anne Yael Nossent, Susana Novella, Georgios Kararigas, Thomas Thum, Costanza Emanueli, Yvan Devaux, Fabio Martelli

Summary: Diabetes mellitus, a metabolic disorder characterized by high blood glucose levels, is a major risk factor for cardiovascular diseases. Chronic or intermittent hyperglycemia in diabetes leads to vascular damage and inflammation, resulting in micro- and macro-vascular diseases. Non-coding RNAs (ncRNAs) may play a fundamental role in the interaction between immune and cardiovascular cells in diabetic complications. This review explores the function of ncRNAs as biomarkers and treatment targets, as well as their involvement in the increased cardiovascular risk in diabetic patients with Sars-CoV-2 infection.

CARDIOVASCULAR DIABETOLOGY (2023)

Editorial Material Cardiac & Cardiovascular Systems

Call for participation in the AtheroNET COST Action to implement multiomics in atherosclerotic cardiovascular disease research

Miron Sopic, Georgios Kararigas, Yvan Devaux, Paolo Magni

EUROPEAN HEART JOURNAL (2023)

Review Microbiology

Sex-Related Effects of Gut Microbiota in Metabolic Syndrome-Related Diabetic Retinopathy

Andrea Garcia-Llorca, Georgios Kararigas

Summary: Metabolic syndrome (MetS) is a complex disease involving metabolic abnormalities and is associated with an increased risk of cardiovascular disease (CVD). Diabetic retinopathy (DR) is a major complication in type 2 diabetic (T2D) patients and can lead to vision loss. The gut microbiota, with their composition and diversity, have been identified as potential risk factors for the development of MetS, T2D, DR, and CVD. Biomarkers are used to monitor biological processes, therapeutic responses, and detect pathogenic disorders. This article discusses the molecular mechanisms of MetS, the role of biological sex in MetS-related DR and gut microbiota, and the latest advances in biomarker research.

MICROORGANISMS (2023)

Article Physiology

Sex-biased and sex hormone-dependent regulation of apolipoprotein A1

Anja Angelov, Paul J. Connelly, Christian Delles, Georgios Kararigas

Summary: This article summarizes the pronounced sex differences in the development and outcome of APOA1 and discusses the sex-biased and sex hormone-dependent regulation of APOA1. The authors suggest that studying the effects of biological sex will contribute to a better understanding of the role of APOA1 in cardiovascular physiology and its sex-biased association with CVD. They also emphasize the need for more sex-stratified data in situations of sex hormone therapy or inhibition.

CURRENT OPINION IN PHYSIOLOGY (2023)

Article Cardiac & Cardiovascular Systems

Sex-Related Effects on Cardiac Development and Disease

Georgios Siokatas, Ioanna Papatheodorou, Angeliki Daiou, Antigone Lazou, Konstantinos E. Hatzistergos, Georgios Kararigas

Summary: Cardiovascular diseases are the leading cause of death and disability, and male and female patients show significant differences in disease mechanisms and treatment responses. This review discusses the current knowledge and gaps in understanding the relationship between heart development and primary and secondary sex determination factors. The influence of abnormal sex determination on cardiovascular manifestations in humans and different species, as well as the role of sex hormones in cardiac repair mechanisms, are specifically covered. Understanding the sex determination-heart axis may lead to new therapeutic approaches for cardiac regeneration and repair.

JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE (2022)

No Data Available